Optimised Osmolality in Oral Supplements Optimised Osmolality in Oral Supplements
NCT ID: NCT07231666
Last Updated: 2025-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2021-11-11
2022-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electrolyte Profile, Nutritional Status and Ileostomy Formation.
NCT02036346
A Trial to Investigate the Effect of Different Supplements on Fluid and Sodium Status in Short Bowel
NCT02686606
Diluted and Undiluted Enteral Nutrition
NCT06516835
Fortified Foods in Older Inpatients
NCT03176030
Effect of Glutamine and Vitamin C on Interleukin-6 and Clinical Outcomes in Surgical Intensive Care Unit Patients
NCT03166956
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hypoosmolar
One with a hypo-osmolar fluid
water
oral commercially available supplements
isoosmolar
one with an iso-osmolar fluid
semi skimmed milk or powerade
oral commercially available supplements
hyperosmolar
one with a hyper-osmolar
juice
oral commercially available supplements
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
water
oral commercially available supplements
semi skimmed milk or powerade
oral commercially available supplements
juice
oral commercially available supplements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. ileostomy formed at least 8 weeks before enrolment
3. consent to participate
Exclusion Criteria
2. known chronic kidney disease
3. known diabetes mellitus
4. too long driving distance
5. parenteral nutrition/fluid more than 6 litres per month
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of medicine V (Hepatology and Gastroenterology)
Aarhus C, , Denmark
Aarhus University Hospital
Aarhus N, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Quist JR, Rud CL, Frumer K, Julsgaard M, Dahl Baunwall SM, Hvas CL. Osmolality in oral supplements drives ileostomy output: Defining the Goldilocks zone. Clin Nutr ESPEN. 2024 Jun;61:88-93. doi: 10.1016/j.clnesp.2024.03.003. Epub 2024 Mar 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-10-72-289-21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.